Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
AbstractColon cancer remains a clinical challenge in industrialised countries. Its treatment with 5-Flurouracil (5-FU) develops many side effects and resistance. Thus, several strategies have been undertaken so far, including the use of drug cocktails and polypharmacology. Heme oxygenase-1 (HO-1) is...
Saved in:
Main Authors: | Loredana Salerno (Author), Antonietta Notaro (Author), Valeria Consoli (Author), Federica Affranchi (Author), Valeria Pittalà (Author), Valeria Sorrenti (Author), Luca Vanella (Author), Michela Giuliano (Author), Sebastiano Intagliata (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation
by: Loredana Salerno, et al.
Published: (2021) -
Protective and Detrimental Role of Heme Oxygenase-1
by: Sorrenti, Valeria
Published: (2019) -
The Inhibition of Neuropathic Pain Incited by Nerve Injury and Accompanying Mood Disorders by New Heme Oxygenase-1 Inducers: Mechanisms Implicated
by: Irene Suárez-Rojas, et al.
Published: (2023) -
Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis <i>In Vitro</i>
by: Marco Raffaele, et al.
Published: (2019) -
Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway
by: Montse Pérez-Fernández, et al.
Published: (2023)